Q2 2025 Holdings
Filed 2025-08-13 | 52 holdings | $261.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Maximus Inc(MMS) | COM | 577933104 | $38.5M | 548,086 | 14.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $15.1M | 284,787 | 5.8% |
| Globus MED Inc(GMED) | CL A | 379577208 | $14.5M | 245,570 | 5.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $14.2M | 262,500 | 5.4% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $13.8M | 173,951 | 5.3% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $13.4M | 512,338 | 5.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $12.7M | 100,725 | 4.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $12.4M | 225,114 | 4.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $9.8M | 4,095,764 | 3.8% |
| Idexx Labs Inc(IDXX)Put | COM | 45168D104 | $9.7M | 18,000 | 3.7% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $9.1M | 187,500 | 3.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $7.8M | 810,274 | 3.0% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $7.4M | 112,923 | 2.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $7.1M | 539,730 | 2.7% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $7.0M | 1,839,022 | 2.7% |
| Septerna Inc(SEPN) | COM | 81734D104 | $6.2M | 584,435 | 2.4% |
| Artivion Inc(AORT) | COM | 228903100 | $4.9M | 158,736 | 1.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $4.4M | 236,070 | 1.7% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $4.2M | 2,075,139 | 1.6% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $4.0M | 3,735,396 | 1.5% |
| Avanos MED Inc(AVNS) | COM | 05350V106 | $3.5M | 288,849 | 1.4% |
| Merus N V | COM | N5749R100 | $3.3M | 62,719 | 1.3% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.1M | 947,489 | 1.2% |
| Inmune BIO Inc(INMB)Put | COM | 45782T105 | $3.0M | 1,299,300 | 1.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $2.8M | 1,307,964 | 1.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $2.7M | 241,000 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.6M | 124,230 | 1.0% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $2.4M | 335,937 | 0.9% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $2.4M | 478,343 | 0.9% |
| Neuroone MED Technologies Co(NMTC) | COM NEW | 64130M209 | $2.4M | 3,523,663 | 0.9% |
| Senseonics Hldgs Inc(SENS1GBP) | COM | 81727U105 | $2.3M | 4,852,298 | 0.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.8M | 122,210 | 0.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $1.7M | 1,369,748 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $1.7M | 318,256 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $1.7M | 726,851 | 0.6% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.4M | 178,774 | 0.5% |
| Tela BIO Inc(TELA) | COM | 872381108 | $1.2M | 636,300 | 0.5% |
| Alector Inc(ALEC) | COM | 014442107 | $1.2M | 845,531 | 0.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $879.0K | 1,341,636 | 0.3% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $736.3K | 2,232,000 | 0.3% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $585.4K | 785,824 | 0.2% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $577.6K | 122,889 | 0.2% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $472.1K | 279,369 | 0.2% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $380.3K | 50,839 | 0.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $360.1K | 72,173 | 0.1% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $302.0K | 31,169 | 0.1% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $165.3K | 163,679 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $60.4K | 131,300 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $37.7K | 10,100 | 0.0% |
| Humacyte Inc | *W EXP 08/27/202 | 44486Q111 | $18.7K | 49,998 | 0.0% |